In a breakthrough that could transform cancer care, Guardant Health’s new study—RADIOHEAD—suggests that its tissue-free, blood-based test, Guardant Reveal, can…
Browsing: Clinical Updates
GLP-1 receptor agonists like semaglutide have transformed obesity care, offering dramatic weight loss and improved cardiometabolic outcomes. But according to…
Two major reviews from Dana-Farber Cancer Institute spotlight a global surge in gastrointestinal (GI) cancers among adults under 50—with colorectal…
AGA presents a new season of Inside Scope based off the Perspectives column from our newspaper, GI & Hepatology News.…
2025 is bringing a wave of groundbreaking advancements in gastrointestinal care, with emerging technologies that aim to improve GI diagnoses,…
Viome Life Sciences and Scripps Research have partnered to develop the first RNA-based at-home test to detect precancerous colon polyps—aiming…
Geneoscopy has received FDA approval for an updated, simplified stool collection method for ColoSense®, its RNA-based colorectal cancer (CRC) screening…
In a landmark study published in Nature, Duke University researchers unveiled a “sixth sense” that allows the brain to respond…
A new study in The Lancet suggests that a simple capsule-sponge test could safely replace endoscopy for low-risk patients with…
The National Cancer Institute has enrolled the first patient in its Vanguard Study to evaluate Guardant Health’s Shield™ multi-cancer detection…